Applying natural language learning and deep neural networks to mortality risk models could help predict cardiovascular outcomes with more accuracy than modern support vector machines, researchers said at the 67th annual American College of Cardiology conference in Orlando.

Surgical risk is an outdated measure of a patient’s eligibility for aortic valve replacement procedures, one Norfolk, Virginia, cardiologist said at the American College of Cardiology’s annual symposium last weekend—clinicians should instead be turning their attention to the idea of “TAVR suitability.”

ALAMEDA, Calif., March 13, 2018 — Cardiac troponin I (cTnI) concentrations measured with the Singulex ultrasensitive cTnI assay, powered by Single Molecule Counting technology, were associated with a higher prevalence of coronary artery disease (CAD) and independently predicted cardiovascular events in patients with obstructive and non-obstructive CAD, according to a study published in the Journal of the American Heart Association.

MINNEAPOLIS, March 14, 2018 — Mardil Medical, Inc., today announced the first human implants of its VenTouch® Triad device. Designed as a combination therapy to simultaneously treat the dilated ventricle and the resulting distorted valve in patients suffering from Type IIIb Functional Mitral Valve Regurgitation (FMR), VenTouch is a less-invasive treatment for a condition that can, if left untreated, accelerate and worsen heart failure.

Generic clopidogrel was equally effective as the brand-name antiplatelet Plavix for an older population with acute coronary syndrome (ACS), according to a study published in Circulation: Cardiovascular Quality and Outcomes.

A chest patch that records heartbeat patterns could potentially be a better detector of atrial fibrillation (AFib) and subsequently can expedite more timely treatment than traditional treatment, according to new research presented at the American College of Cardiology's 67th Annual Scientific Session.

Long-term dual antiplatelet therapy (DAPT) should remain the standard of care following implantation of drug-eluting stents, suggests research presented March 12 at the American College of Cardiology’s annual scientific session and published simultaneously online in The Lancet.

More than a quarter million deaths from cardiovascular disease (CVD) each year in the United States can be attributed to historical lead exposure in people age 44 and older, according to new estimates published in The Lancet Public Health.